OpenURL Connection Search

Select item for more details and to access through your institution.

Fractionated doses of gemtuzumab ozogamicin combined with 3 + 7 induction chemotherapy as salvage treatment for young patients with acute myeloid leukemia in first relapse.
Published in:
2012
By:
- Malfuson JV;
- Konopacki J;
- Thepenier C;
- Eddou H;
- Foissaud V;
- de Revel T;
- Malfuson, J V;
- Konopacki, J;
- Thepenier, C;
- Eddou, H;
- Foissaud, V;
- de Revel, T
Publication type:
journal article
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
Published in:
2000
By:
- Thomas, X.;
- Dombret, H.;
- Cordonnier, C.;
- Pigneux, A.;
- Gardin, C.;
- Guerci, A.;
- Vekhoff, A.;
- Sadoun, A.;
- Stamatoullas, A.;
- Fegueux, N.;
- Maloisel, F.;
- Cahn, J. Y.;
- Reman, O.;
- Gratecos, N.;
- Berthou, C.;
- Huguet, F.;
- Kotoucek, P.;
- Travade, P.;
- Buzyn, A.;
- de Revel, T.
Publication type:
journal article
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial).
Published in:
1999
By:
- Thomas, X.;
- Fenaux, P.;
- Dombret, H.;
- Delair, S.;
- Dreyfus, F.;
- Tilly, H.;
- Vekhoff, A.;
- Cony-Makhoul, P.;
- Leblond, V.;
- Troussard, X.;
- Cordonnier, C.;
- de Revel, T.;
- Simon, M.;
- Nicolini, F.;
- Stoppa, A. M.;
- Janvier, M.;
- Bordessoule, D.;
- Rousselot, P.;
- Ffrench, M.;
- Marie, J. P.
Publication type:
journal article
Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia. Club de Réflexion en Hématologie.
Published in:
1997
By:
- Gardin, C;
- Chaibi, P;
- de Revel, T;
- Rousselot, P;
- Turlure, P;
- Micléa, J M;
- Nédellec, G;
- Dombret, H
Publication type:
journal article
Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 6, p. 819, doi. 10.1038/bmt.2012.241
By:
- Bergeron, A;
- Godet, C;
- Chevret, S;
- Lorillon, G;
- Peffault de Latour, R;
- de Revel, T;
- Robin, M;
- Ribaud, P;
- Socié, G;
- Tazi, A
Publication type:
Article
Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AML.
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 11, p. 1436, doi. 10.1038/bmt.2012.49
By:
- Hospital, M A;
- Thomas, X;
- Castaigne, S;
- Raffoux, E;
- Pautas, C;
- Gardin, C;
- Bourhis, J-H;
- Reman, O;
- de Revel, T;
- Terré, C;
- Preudhomme, C;
- Fenaux, P;
- Michallet, M;
- Socié, G;
- Dombret, H
Publication type:
Article
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.
Published in:
Bone Marrow Transplantation, 2005, v. 35, n. 8, p. 767, doi. 10.1038/sj.bmt.1704884
By:
- de Labarthe, A;
- Pautas, C;
- Thomas, X;
- de Botton, S;
- Bordessoule, D;
- Tilly, H;
- de Revel, T;
- Bastard, C;
- Preudhomme, C;
- Michallet, M;
- Fenaux, P;
- Bastie, J-N;
- Socié, G;
- Cordonnier, C;
- Dombret, H
Publication type:
Article
SP/drug efflux functionality of hematopoietic progenitors is controlled by mesenchymal niche through VLA-4/CD44 axis.
Published in:
2014
By:
- Malfuson, J-V;
- Boutin, L;
- Clay, D;
- Thépenier, C;
- Desterke, C;
- Torossian, F;
- Guerton, B;
- Anginot, A;
- de Revel, T;
- Lataillade, J-J;
- Le Bousse-Kerdilès, M-C
Publication type:
journal article
SP/drug efflux functionality of hematopoietic progenitors is controlled by mesenchymal niche through VLA-4/CD44 axis.
Published in:
Leukemia (08876924), 2014, v. 28, n. 4, p. 853, doi. 10.1038/leu.2013.256
By:
- Malfuson, J-V;
- Boutin, L;
- Clay, D;
- Thépenier, C;
- Desterke, C;
- Torossian, F;
- Guerton, B;
- Anginot, A;
- de Revel, T;
- Lataillade, J-J;
- Le Bousse-Kerdilès, M-C
Publication type:
Article
Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
Published in:
Leukemia (08876924), 2012, v. 26, n. 6, p. 1247, doi. 10.1038/leu.2011.382
By:
- Renneville, A;
- Boissel, N;
- Nibourel, O;
- Berthon, C;
- Helevaut, N;
- Gardin, C;
- Cayuela, J-M;
- Hayette, S;
- Reman, O;
- Contentin, N;
- Bordessoule, D;
- Pautas, C;
- Botton, S de;
- Revel, T de;
- Terre, C;
- Fenaux, P;
- Thomas, X;
- Castaigne, S;
- Dombret, H;
- Preudhomme, C
Publication type:
Article
Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.
Published in:
Leukemia (08876924), 2007, v. 21, n. 3, p. 453, doi. 10.1038/sj.leu.2404521
By:
- Thomas, X.;
- Raffoux, E.;
- Botton, S. de;
- Pautas, C.;
- Arnaud, P.;
- de Revel, T.;
- Reman, O.;
- Terré, C.;
- Corront, B.;
- Gardin, C.;
- Le, Q.-H.;
- Quesnel, B.;
- Cordonnier, C.;
- Bourhis, J.-H.;
- Elhamri, M.;
- Fenaux, P.;
- Preudhomme, C.;
- Michallet, M.;
- Castaigne, S.;
- Dombret, H.
Publication type:
Article
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.
Published in:
2007
By:
- Taksin, A.-L.;
- Legrand, O.;
- Raffoux, E.;
- de Revel, T.;
- Thomas, X.;
- Contentin, N.;
- Bouabdallah, R.;
- Pautas, C.;
- Turlure, P.;
- Reman, O.;
- Gardin, C.;
- Varet, B.;
- de Botton, S.;
- Pousset, F.;
- Farhat, H.;
- Chevret, S.;
- Dombret, H.;
- Castaigne, S.
Publication type:
journal article
Activités physiques et hémopathies malignes: le rôle du médecin du sport.
Published in:
SSEM-Journal, 2016, v. 64, n. 4, p. 20, doi. 10.34045/ssem/2016/22
By:
- Bigard, X.;
- Rivière, D.;
- de Revel, T.
Publication type:
Article
Veno-occlusive disease after an anti-CD33 therapy (gemtuzumab ozogamicin).
Published in:
British Journal of Haematology, 2002, v. 116, n. 4, p. 924, doi. 10.1111/j.1467-8535.2007.00703.x
By:
- Bastie, J.N.;
- Suzan, F.;
- Garcia, I.;
- Isnard, F.;
- de Revel, T.;
- Terre, C.;
- Mayeur, D.;
- Abraham, C.;
- Lavielle, R.;
- Castaigne, S.
Publication type:
Article
Granulocytic Sarcoma in a Nonleukemic Patient: Place of Radiotherapy and Systemic Therapies.
Published in:
2011
By:
- Chargari, C.;
- Jacob, J.;
- Bauduceau, O.;
- Ferrand, F. R.;
- de Revel, T.;
- Védrine, L.
Publication type:
Case Study
Which Role for Rituximab in Hairy Cell Leukemia? Reflections on Six Cases.
Published in:
Acta Haematologica, 2010, v. 123, n. 2, p. 110, doi. 10.1159/000270903
By:
- Malfuson, J. V.;
- Fagot, T.;
- Konopacki, J.;
- Souleau, B.;
- Cremades, S.;
- De Revel, T.
Publication type:
Article
L'aplasie médullaire secondaire à un accident d'irradiation : options thérapeutiques et évolution des concepts.
Published in:
Canadian Journal of Physiology & Pharmacology, 2002, v. 80, n. 7, p. 694, doi. 10.1139/y02-095
By:
- de Revel, T.;
- Fagot, T.;
- Souleau, B.;
- Dormont, D.;
- Nedellec, G.
Publication type:
Article

Found: 17